Decoy Therapeutics Inc. Conversion of Stock, Shares Converted
Decoy Therapeutics Inc. (DCOY) had Conversion of Stock, Shares Converted of 6.97 million shares as of 2015-02-03, per its 10-K filed 2018-03-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2018-03-07
- 2015-02-03: Conversion of Stock, Shares Converted 6.97M shares.
| Period end | Conversion of Stock, Shares Converted |
|---|---|
| 2015-02-03 | 6.97M shares 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |